# PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US

> **NCT04582266** · — · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 54 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Remdesivir

## Key facts

- **NCT ID:** NCT04582266
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-31
- **Primary completion:** 2022-04-13
- **Final completion:** 2022-04-13
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2023-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04582266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04582266, "PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04582266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*